Humana (NYSE:HUM) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Humana Inc. (NYSE:HUM). In a filing disclosed on March 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Humana stock on February 26th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Sterling Infrastructure NASDAQ: STRL on 3/3/2025.
• Purchased $1,001 - $15,000 in shares of Hillman Solutions NASDAQ: HLMN on 3/3/2025.
• Sold $1,001 - $15,000 in shares of Ford Motor NYSE: F on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of Uber Technologies NYSE: UBER on 2/26/2025.
• Sold $15,001 - $50,000 in shares of UnitedHealth Group NYSE: UNH on 2/26/2025.
• Purchased $15,001 - $50,000 in shares of Microsoft NASDAQ: MSFT on 2/26/2025.
• Sold $1,001 - $15,000 in shares of General Motors NYSE: GM on 2/26/2025.
• Purchased $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 2/26/2025.
• Sold $1,001 - $15,000 in shares of Akamai Technologies NASDAQ: AKAM on 2/26/2025.
• Sold $1,001 - $15,000 in shares of Danaher NYSE: DHR on 2/26/2025.

Humana Price Performance

Shares of HUM stock traded down $1.04 during trading on Tuesday, hitting $250.21. The company had a trading volume of 1,387,512 shares, compared to its average volume of 1,676,628. The firm has a market capitalization of $30.19 billion, a P/E ratio of 25.15, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The stock's 50-day moving average price is $271.74 and its 200 day moving average price is $282.37.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Equities analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.41%. Humana's dividend payout ratio (DPR) is presently 35.58%.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.32% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Piper Sandler raised their target price on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Cantor Fitzgerald reissued a "neutral" rating and set a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Morgan Stanley reduced their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $283.00 target price on shares of Humana in a research note on Wednesday, February 12th. Twenty research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $285.68.

Institutional Trading of Humana

Several institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in shares of Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock valued at $3,254,899,000 after purchasing an additional 1,751,857 shares during the last quarter. Dodge & Cox grew its holdings in Humana by 106.7% during the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after acquiring an additional 5,264,045 shares during the period. State Street Corp raised its position in shares of Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider's stock worth $1,701,582,000 after acquiring an additional 53,272 shares in the last quarter. Pzena Investment Management LLC lifted its stake in shares of Humana by 44.0% in the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after purchasing an additional 1,103,132 shares during the period. Finally, FMR LLC grew its stake in Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock worth $1,073,387,000 after purchasing an additional 643,291 shares during the period. 92.38% of the stock is currently owned by institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.